Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,341,163
-
Share change
-
+7,522,573
-
Total reported value
-
$365,946,431
-
Put/Call ratio
-
4.4%
-
Price per share
-
$9.80
-
Number of holders
-
133
-
Value change
-
+$73,113,532
-
Number of buys
-
67
-
Number of sells
-
59
Institutional Holders of SCICLONE PHARMACEUTICALS INC - COM (SCLN) as of Q1 2017
As of 31 Mar 2017,
SCICLONE PHARMACEUTICALS INC - COM (SCLN) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,341,163 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, Nantahala Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, Stonepine Capital Management, LLC, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, and Bank of New York Mellon Corp.
This page lists
133
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.